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HBV replicationRobust hepatitis B virus (HBV) replication is stimulated by the regulatory HBx protein. HBx binds the cellular
protein DDB1; however, the importance of this interaction for HBV replication remains unknown. We tested
whether HBx binding to DDB1 was required for HBV replication using a plasmid based replication assay in
HepG2 cells. Three DDB1 binding-deﬁcient HBx point mutants (HBx69, HBx90/91, HBxR96E) failed to restore
wildtype levels of replication from an HBx-deﬁcient plasmid, which established the importance of the
HBx-DDB1 interaction for maximal HBV replication. Analysis of overlapping HBx truncation mutants revealed
that both the HBx-DDB1 binding domain and the carboxyl region are required for maximal HBV replication both
in vitro and in vivo, suggesting the HBx-DDB1 interaction recruits regulatory functions critical for replication. Finally
we demonstrate that HBx localizes to the Cul4A-DDB1 complex, and discuss the possible implications formodels of
HBV replication.
© 2012 Elsevier Inc. All rights reserved.Introduction
Hepatitis B virus (HBV) infection is a serious health problem
worldwide, with greater than 350 million people chronically infected
and at risk for developing serious liver disease, including cirrhosis, ﬁ-
brosis, and hepatocellular carcinoma (Beasley, 1988; Seeger et al.,
2007). HBV is a 3.2-kb, partially double-stranded DNA virus that has
four overlapping reading frames, which encode seven viral proteins:
three surface antigens, a polymerase, two core proteins, and HBx.
The HBx protein is the sole HBV regulatory protein and it has multiple
functions both in vitro and in vivo, including transactivation of cellular
and viral promoters (Spandau and Lee, 1988; Twu and Schloemer,
1987), activation of signaling pathways (Benn and Schneider, 1994;
Cross et al., 1993), alteration of cell cycle progression (Benn and
Schneider, 1995; Gearhart and Bouchard, 2010; Hodgson et al.,
2008; Koike et al., 1994; Madden and Slagle, 2001), induction or pre-
vention of apoptosis [reviewed in Bouchard and Schneider, 2004],
and inhibition of cellular DNA repair (Becker et al., 1998; Groisman
et al., 1999; Madden et al., 2000; Prost et al., 1998). HBx also acts as
a tumor promoter in transgenic mice (Madden et al., 2001;
Terradillos et al., 1997). HBx localizes to both the cytoplasm and the
nucleus, where it presumably has different functions [reviewed in
Bouchard and Schneider, 2004]. With the establishment of a85, Houston, TX 77030, USA.
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rights reserved.plasmid-based HBV replication assay, it is now known that HBx is re-
quired for maximal virus replication (Bouchard et al., 2002; Keasler
et al., 2007; Leupin et al., 2005; Tang et al., 2005) although the mech-
anism by which HBx facilitates HBV replication remain unclear.
HBx interacts with several cellular proteins and may mediate its role
in virus replication through these interactions. The most well-
characterized HBx binding partner is the damage-speciﬁc DNA binding
protein 1 (DDB1) (Lee et al., 1995; Sitterlin et al., 1997; Lin-Marq et al.,
2001) [reviewed inKeasler and Slagle, 2008]. DDB1 is a highly conserved,
functional protein expressed in both the nucleus and cytoplasm (Liu et
al., 2000). The interaction between HBx and DDB1 is conserved among
the HBx proteins from all mammalian hepadnaviruses (Sitterlin et al.,
1997), suggesting an important role for this interaction in virus replica-
tion. Further, interaction of thewoodchuck hepatitis virus (WHV) X pro-
tein (WHx) with DDB1 is critical for WHV replication in woodchucks
(Sitterlin et al., 2000). The minimal DDB1 binding domain on HBx has
been identiﬁed by several laboratories to be amino acids 88–100
(HBx88–100) (Fig. 1A).
DDB1 functions as an adaptor protein for the Cul4A E3 ubiquitin li-
gase complex (Angers et al., 2006; Higa et al., 2006; Shiyanov et al.,
1999). DDB1 recruits DDB1 Cullin Associated Factors (DCAFs),
which in turn recruit substrates to the DDB1-Cul4A complex for sub-
sequent ubiquitination and degradation by the proteosome (Angers
et al., 2006; He et al., 2006; Higa et al., 2006). In this manner, DDB1
plays important roles in diverse cellular processes, such as DNA synthe-
sis, gene expression, cell division, and apoptosis. The DCAFs have in com-
mon a 16-aa DDB1-bindingWD40 (DWD)motif that is characterized not
by amino acid sequence, but rather by the biophysical/biochemical char-
acteristics of those amino acids (He et al., 2006). The minimal DDB1-
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Fig. 1. HBx point mutants that do not bind DDB1 fail to restore HBx-deﬁcient replication. (A) Schematic representation of HBx protein showingminimumdomain required for binding to
DDB1 [adapted fromKeasler and Slagle, 2008]. (B) Schematic ofwildtype and pointmutant HBx proteins. DDB1 binding determined previously (Becker et al., 1998; Lin-Marq et al., 2001).
(C) Quantitation of capsid-associated viral DNA as described in Materials and methods section. Mean copy number from cells transfected with pHBV was set to 100% and compared to
others. Error bars (SE) from three independent experiments. Statistical signiﬁcance compared to pHBV is noted by an asterisk (pb0.05). (D) Western blot detection of wildtype and
point mutant HBx proteins with rabbit anti-HBx.
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of DWD motifs in cellular DCAFs (Keasler and Slagle, 2008; Li et al.,
2010). A recent high resolution crystal structure demonstrated the direct
interaction betweenDDB1 and anHBx88–100 peptide (Li et al., 2010). The
speciﬁc region on DDB1 to which HBx binds is shared with at least 79
other DCAFs (He et al., 2006). This raises the possibility that HBx binding
to DDB1 may beneﬁt virus replication by displacing DCAFs and thereby
altering the spectrum of DCAFs and their substrates recruited to the
Cul4A complex.
In the present study, we used the plasmid-based HBV replication
assay in cultured HepG2 cells and in hydrodynamically injected
mice to investigate the contribution of the HBx-DDB1 interaction to
HBV replication. Three HBx point mutant proteins that no longer
bind DDB1 were unable to restore HBx-deﬁcient replication, demon-
strating that the HBx-DDB1 interaction is required for maximal HBV
replication. However, further analysis of HBx truncation mutants
revealed that HBx-DDB1 binding is not sufﬁcient to restore HBx-
deﬁcient replication, and that an additional function(s) residing in
the carboxyl half of the HBx protein is essential for maximal
replication.
Results
HBx interaction with DDB1 is required for virus replication
The importance of the HBx-DDB1 interaction has been suggested
by the observation that an HBx point mutant that no longer binds to
DDB1 (HBxR96E) was unable to restore HBx-deﬁcient pHBVΔXreplication (Leupin et al., 2005). In the present study, the same
plasmid-based HBV replication assay that requires HBx expression
for maximal virus replication was used to investigate the HBx-DDB1-
mediated requirements for HBV replication. Human liver HepG2 cells
were transfected with a plasmid encoding a greater-than-genome
length (129%) HBV genome (pHBV) (Melegari et al., 1998) or an identi-
cal plasmid encoding HBV with a point mutation in the X open reading
frame that prevents HBx expression (pHBVΔX) (Scaglioni et al., 1997).
Cells receiving pHBVΔXwere additionally co-transfectedwith plasmids
encoding HBx proteins that either bind DDB1 (e.g., HBx, HBx7) or do not
(HBx69, HBx90/91, HBxR96E) (Fig. 1B). Quantitation of capsid-associated
DNA revealed that HBx-deﬁcient replication frompHBVΔXwas reduced
by approximately 60% compared to wildtype pHBV (Fig. 1C). Replica-
tion from pHBVΔX was restored to wildtype pHBV levels by co-
transfection of a secondplasmid encodingHBxWT, as reported previous-
ly (Bouchard et al., 2002; Keasler et al., 2007, 2009; Kumar et al., 2011;
Leupin et al., 2005; Tang et al., 2005) and also by the HBx7 point mutant
that retained DDB1-binding (Fig. 1C). Importantly, the three HBx point
mutants that do not bind DDB1 failed to restore pHBVΔX replication.
We have previously shown that the amount of HBx required for maxi-
mal replication in the HepG2 assay is well below the limit of detection
by our sensitive western blot assay (Keasler et al., 2009). Therefore, ex-
pression of these HBx mutants at detectable levels (Fig. 1D) indicates
that sufﬁcient protein was present to restore HBVΔX replication. No
conclusions can be drawn from this experiment regarding the relative
levels of the HBx and mutant proteins, as we are not certain the poly-
clonal anti-HBx serum reacts equally with all HBx proteins. Together,
these results conﬁrm the previous ﬁnding that HBxR96E is unable to
75A.:A.J. Hodgson et al. / Virology 426 (2012) 73–82restore pHBVΔX (Leupin et al., 2005), and extends that result to include
two additional HBx mutants that lack DDB1-binding (HBx69, HBx90/91).
We conclude that the interaction of HBx with DDB1 is required for
maximal virus replication in this assay.
HBx interaction with DDB1 is not sufﬁcient for virus replication
DDB1 functions as an adaptor protein that recruits DCAFs to the
Cul4A E3 ligase complex for ubiquitination (Angers et al., 2006; He
et al., 2006; Higa et al., 2006; Shiyanov et al., 1999). HBx binds to a
site on DDB1 (Li et al., 2010) to which at least 79 DCAFs bind (He
et al., 2006), and displaces at least two DCAFs (Bontron et al., 2002;
Li et al., 2010), presumably altering the spectrum of DCAF-recruited
substrates that are ubiquitinated and degraded. These observations
lead to the question: Is HBx binding to DDB1 sufﬁcient for HBV
replication?
The minimal domain of HBx required for binding to DDB1 contains
aa88–100 (Fig. 1A), and the smallest trunctation mutant used in this
study, HBx55–101, contains the full DDB1 binding site. To determine
whether HBx binding to DDB1 is sufﬁcient to restore replication, we
repeated the wildtype (pHBV) and HBx-deﬁcient (pHBVΔX) replica-
tion assay and tested the ability of co-transfected pSI-XWT, pSI-X55–
101, or a negative control vector alone (pSI) to restore pHBVΔX repli-
cation. Although HBxWT restored HBx-deﬁcient replication, HBx55–101
was unable to increase HBV replication above the levels of pHBVΔX
alone (Fig. 2A), even though this mutant is able to bind DDB1
(Becker et al., 1998).
To conﬁrm this result in vivo, we repeated this experiment using
the hydrodynamic injection model for HBV replication. Groups of
ICR mice were injected with pHBV or pHBVΔX, and mice receiving
pHBVΔX were additionally co-injected with pSI-X, pSI-X55–101, or
empty pSI as a negative control plasmid. Mice were sacriﬁced at 4-
days post injection, a time point that coincides with the peak inA B
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Fig. 2. HBx55–101 is not sufﬁcient to rescue pHBVΔX replication. (A) Quantitation of capsid-
100% and compared to others. Error bars (SEM) are from three independent experiments.
were hydrodynamically injected with plasmid DNA and viremia measured on day 4 post-
(error bars shown are SEM), and statistical signiﬁcance is designated with asterisks. A tota
of wild type and truncation mutant HBx proteins using an anti-HA monoclonal antibody.
the pSI control (lane 1) are considered non-speciﬁc.viremia (Keasler et al., 2007; Yang et al., 2002), and capsid-
associated DNA was quantitated. Mice injected with pHBVΔX had
95% lower viremia than those injected with pHBV (Fig. 2B), which
conﬁrmed our previous results (Keasler et al., 2007, 2009). Reduced
viremia in pHBVΔX-injected mice was restored to maximal levels by
co-injection of pSI-X, but not by the pSI negative control plasmid. Im-
portantly, mice co-injected with pHBVΔX and pSI-X55–101 had vire-
mia at a level similar to mice injected with pHBVΔX alone (Fig. 2B).
These data conﬁrm those obtained in transfected HepG2 cells and
demonstrate that DDB1-binding alone is not sufﬁcient to rescue
HBx-deﬁcient replication. We conclude that, in addition to the
DDB1-binding domain, other regions of HBx are required for maximal
virus replication in this assay.
Rescue of HBVΔX replication requires the HBx carboxyl terminal domain
We next sought to deﬁne the HBx domains that act in concert with
the DDB1 binding domain to restore HBx-deﬁcient replication. We
ﬁrst tested HBx truncations that retained either the amino (aa1–
101) or the carboxyl (aa43–154) half of HBx for their ability to restore
HBx-deﬁcient replication in HepG2 cells (Fig. 3A). Although both
truncations included the full DDB1-binding domain, HBx-deﬁcient
replication was restored to maximal levels by the HBx43–154 carboxyl
half of HBx, but not by the amino half HBx1–101 truncation mutant
(Fig. 3B). Expression of HBx1–101 and HBX43–154 was conﬁrmed by
western blot (Fig. 2C, lanes 3 and 5). These results indicate that the
amino terminal 42 aa of HBx was dispensable for replication in this
assay, and that the carboxyl portion of HBx (aa43–154) was sufﬁcient
for HBV replication in HepG2 cells. The observation that both HBx1–
101 and HBx43–154 contained the DDB1-binding domain (Fig. 3A), yet
only HBx43–154 restored HBx-deﬁcient replication, further supports
the conclusion that the DDB1-binding region alone is not sufﬁcient
to restore HBx-deﬁcient replication.XW
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Fig. 3. HBx43–154 is sufﬁcient to restore pHBVΔX replication. (A) Schematic representation of HBx protein and truncation mutants. Gray box indications the region of HBx known to
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terminal domain downstream of the DDB1 binding domain, i.e.,
HBx101–154 (Fig. 4A) could restore pHBVΔX replication. While HBxWT
was able to restore HBx-deﬁcient replication, truncation mutants
HBx55–101 and HBx101–154 failed to do so either when transfected singly
or co-transfected (Fig. 4B). These results indicate that both the DDB1-
binding domain and the carboxyl half of HBx are required for HBV repli-
cation and that these two function in cis to potentiate HBV replication.
HBx transactivation of HBV Enhancer 1
HBx is well known as a broadly-acting transcriptional coactivator
that augments the expression of both viral and cellular genes
(Spandau and Lee, 1988; Twu and Schloemer, 1987) [reviewed in
Bouchard and Schneider, 2004]. Our results above suggest that, in ad-
dition to DDB1 binding, the carboxyl portion of HBx also functions to
restore HBx-deﬁcient replication in HepG2 cells. Therefore, we next
tested the ability of select HBx truncation mutants to transactivate
an HBV Enhancer 1 (ENH1) luciferase reporter. HepG2 cells were
co-transfected with plasmids encoding luciferase reporters and con-
structs expressing full length or truncated HBx. Transactivation was
then measured using the dual luciferase assay (see Materials and
methods). Expression of HBxWT led to a modest but reproducible
1.5-fold transactivation of ENH1-Luc expression (Fig. 4C), a result
consistent with other studies reporting a 2- to 4-fold transactivationFig. 4. HBx101–154 does not restore HBx-deﬁcient replication. (A) Schematic representation o
Mean copy number from cells transfected with pHBV was set to 100% and compared to ot
transactivation of HBV ENH1-luciferase. Normalized transactivation from cells receiving pSI w
HBx. Error bars (SEM) are from three to ﬁve independent experiments. Asterisks indicate statiof ENH1 luciferase by HBx (Cha et al., in press; Tang et al., 2005).
The truncation mutant HBx43–154 transactivated ENH1 luciferase to
the same level as full length HBx. However, when the DDB1-binding
domain was removed from the carboxyl terminus (e.g., HBx101–154)
transactivation of ENH1-Luc was signiﬁcantly reduced (Fig. 4C).
HBx1–101, which lacks the carboxyl half of HBx, also transactivated
ENH1 to levels signiﬁcantly less than HBxWT. These results demon-
strate that the DDB1-binding domain, and/or some other function(s)
associated with that region of HBx was required for this transactiva-
tion function.
HBx localizes to the Cul4A-DDB1 complex
DDB1 is an adaptor protein for the Cul4A E3 ligase complex, which
ubiquitinates protein substrates to promote their degradation
(Angers et al., 2006; He et al., 2006; Higa et al., 2006; Shiyanov
et al., 1999). A recent study by Li et al. (2010) demonstrated that
HBx expressed as a GFP fusion protein (GFP-HBx) forms a complex
with HA-DDB1 and myc-Cul4A. We next determined whether HBx
(without a GFP tag) similarly is found in the Cul4A-DDB1 complex.
HBx was detected by IP/western blot from cells transfected with
pSI-X (Fig. 5). Analysis of the same IP by western blot using anti-
DDB1 demonstrated that endogenous DDB1 was also pulled down
by anti-HBx (Fig. 5, lane 2), a result that conﬁrms previous reports
of the interaction between these two proteins (Lee et al., 1995;f HBx protein and truncation mutants. (B) Quantitation of capsid-associated viral DNA.
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77A.:A.J. Hodgson et al. / Virology 426 (2012) 73–82Sitterlin et al., 1997). In addition, Cul 4A was detected by anti-myc IP/
western from cells transfected with a plasmid encoding myc-tagged
Cul4A (Fig. 5, lane 3), and endogenous DDB1 was similarly detected
by western blot, conﬁrming reports that DDB1 binds to Cul4A
(Angers et al., 2006; Shiyanov et al., 1999). Finally, cells co-
transfectedwith plasmids expressing HBx andmyc-Cul4Awere analyzed
by IP/western, which revealed myc-Cul4A co-precipitating endogenous
DDB1 and HBx (Fig. 5, lane 4). Though small amounts of DDB1 were pre-
cipitated by the myc-speciﬁc antibody, presumably through a complex
formed between DDB1 and endogenous c-myc (Fig. 5, lane 1), co-
transfection of myc-tagged Cul4 without or with HBx substantially in-
creased the amount DDB1 precipitated by the anti-myc antibody (Fig. 5,
lanes 3 and 4). We conclude that HBx can be found in the Cul4A-DDB1
complex, in agreement with the previous study that utilized GFP-HBx
(Li et al., 2010).
DDB1 stabilizes HBx steady-state levels
The DDB1-Cul4A complex recruits substrate proteins for ubiquitina-
tion, which targets them for proteosome degradation. Although HBx
can reside in the DDB1-Cul4A complex, there is only indirect evidence
that DDB1 stabilizes HBx expression rather than promoting its degrada-
tion (Bergametti et al., 2002; Bontron et al., 2002). We used liver tissue
from conditional DDB1 knockout mice to directly examine steady-state
levels of HBx in the presence and absence of DDB1. Mice with ﬂoxed
DDB1 alleles [DDB1F/F, Yamaji et al., 2010] were crossed with mice
transgenic for HBx under control of the alpha-1-anti-trypsin regulatory
region [ATX, Lee et al., 1990] to create DDB1F/F; ATX mice. We further
crossed the DDB1F/F; ATX with mice transgenic for the Cre recombinase
under control of the liver-speciﬁc albumin promoter to promote exci-
sion of the DDB1 gene (DDB1F/F; Alb-Cre+/−, Fig. 6A) in the ATX mice.
DDB1F/F; ATX and DDB1F/F; Alb-Cre+/−; ATX mice were sacriﬁced and
their livers removed to prepare lysates that were examined for DDB1
and HBx protein expression. Western blot analysis of liver lysates for
DDB1 expression demonstrated similar DDB1 levels in ATX (Fig. 6B, lane
2) and DDB1F/F; ATX livers (Fig. 6B, lanes 3 and 4). However, livers from
DDB1F/F; ATX mice that additionally expressed Cre (DDB1F/F; Alb-Cre+/−;
ATX) showed a greater than 90% reduction of DDB1 steady-state levels,
normalized to the tubulin loading control (Fig. 6B, lanes 5 and 6). Immu-
nohistochemical analysis of parafﬁn-embedded liver tissue revealed
DDB1-positive hepatocytes interspersed among DDB1-negative cells, in-
dicating that the Cre-driven deletion of DDB1F/F was not complete inthese 6 week animals (Fig. 6C). The same liver lysates were then tested
by IP/western blot for HBx. The supernatants from the ﬁrst IP were
saved and new anti-HBx antibody was added to recover any HBx not re-
trieved in the ﬁrst IP. Subsequentwestern blot analysis for both rounds of
IP revealed that levels of HBx were highest when DDB1 was present
(Fig. 6D, lanes 2, 3 and 4),while a reduction inDDB1 levelswas associated
with signiﬁcantly lower HBx levels (Fig. 6D, lanes 5 and 6). These results
demonstrate that HBx steady-state levels are increased in the presence of
DDB1, a result that suggests that HBx is stabilized by DDB1. These results
further indicate that HBx is not a target for DDB1-Cul4A-mediated degra-
dation, but may instead be functioning like a DCAF.
Discussion
The function(s) of HBx in virus replication is poorly understood,
although a previous study indicates that HBx binding to cellular
DDB1 is critical for the HBx-mediation potentiation of HBV replication
(Leupin et al., 2005). The goal of the present study was to further in-
vestigate the contribution of the HBx-DDB1 interaction to HBV repli-
cation using plasmid-based replication assays in HepG2 cells and in
hydrodynamically injected mice. The analysis of four different HBx
point mutants ﬁrmly establishes that DDB1-binding to HBx is critical
for maximal HBV replication (Fig. 1). While the HBx-DDB1 interaction
is required, we now report that this binding was not sufﬁcient for
virus replication and that additional regions of HBx residing in the
carboxyl terminus, but not in the amino terminus, are required. We
show that the carboxyl portion of HBx is able to transactivate the
HBV ENH1 Luceriferase reporter, and that removal of the DDB1-
binding domain from the carboxyl region results in a loss of transac-
tivation function. Thus, there is a strong correlation between the res-
toration of HBV replication and HBx transactivation of the HBV ENH1,
suggesting these activities are mechanistically related in this assay.
We demonstrate that HBx is present in the Cul4A-DDB1 E3 ligase
complex, and that endogenous DDB1 is required to stabilize HBx in
mouse liver. These results suggest a model in which HBx uses the in-
teraction with DDB1 to redirect DDB1 function in order to beneﬁt
HBV replication.
Previous conclusions regarding the importance of HBx-DDB1 in
HBV replication were derived from the analysis of the HBxR96E point
mutant protein that can no longer bind DDB1 (Leupin et al., 2005).
It remained possible that the inability of HBxR96E to restore HBx-
deﬁcient replication was due to the loss of an HBx function indepen-
dent of DDB1-binding. Therefore, our ﬁnding that two additional
DDB1-binding defective HBx mutant proteins are similarly unable to
restore HBx-deﬁcient replication ﬁrmly establishes the importance
of the HBx-DDB1 interaction to HBV replication. The present study
used HBx subtype adw2, whereas the study by Leupin et al. (2005)
utilized HBx subtype ayw. Since HBx subtypes differ by 5.8% in
amino acid sequence (Keasler et al., 2007), certain residues within
HBxWT can be varied without affecting the protein's ability to restore
HBx-deﬁcient replication. Our results also highlight the importance of
other HBx residues that when mutated no longer bind DDB1 and are
unable to support HBV replication. We note that the mutation in
HBx69 resides outside of the domain on HBx required for binding to
DDB1. This mutant was created by converting a conserved cysteine
(Kidd-Ljunggren et al., 1995) to a leucine at aa position 69 (Becker
et al., 1998), a change predicted to alter the conformation of that
HBx mutant protein. Other HBx point mutant proteins with changes
in aa-68, -119, -129, and -139 that also reside outside the DDB1 bind-
ing domain have a similar loss of DDB1 binding activity (Sitterlin
et al., 1997). The most likely explanation is that the mutant proteins
have an altered conformation that interferes with the ability of HBx
to bind DDB1. We conclude that the HBx interaction with DDB1 is
critical for virus replication in HepG2 cells.
The analysis of overlapping HBx deletion mutants representing
the entire HBx protein revealed that a function(s) residing in the
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under the control of the Albumin promoter (Alb-Cre+/−). (B) Western blot analysis of DDB1 and tubulin loading control in liver lysates. Numbers below each lane indicate results
of densitometer scanning for DDB1 normalized to tubulin for that lane. (C) Immunostaining for DDB1 protein of liver sections of 6-wk old mice. (D) Sequential IP/western blot detection
HBx expression in liver lysates.
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HepG2 cells (Fig. 3). Interestingly, previous studies have identiﬁed
transcription factor binding sites in the carboxyl terminus of HBx, in-
cluding sites for CREB (Barnabas et al., 1997), TFIIB (Lin et al., 1997),
RPB5 (Lin et al., 1997), CEBPα (Choi et al., 1999), and TBP (Qadri et al.,
1995). Consistent with this, crystallography data predicts that the
carboxyl portion of HBx projects out from the binding pocket on
DDB1 (Li et al., 2010), which would make it available for interactions
with transcription factors. Indeed, the importance of the HBx-DDB1
interaction in transactivation was ﬁrst suggested by a study in
which HBx mutants that did not bind DDB1 also did not transactivate
an AP-1 reporter gene (Sitterlin et al., 1997). In addition, the HBx-
DDB1 interaction was required for coactivation of HBV mRNA, al-
though the HBV ENH1 was not speciﬁcally examined in that study
(Leupin et al., 2005). Our present results further this notion by sug-
gesting that both DDB1-binding and the carboxyl portion of HBx are
required for transactivation of the HBV ENH1 in HepG2 cells
(Fig. 4C). Consistent with this, other studies have demonstrated
transactivation of HBV ENH1 luciferase by HBx51–154 (XpLUC) (Tang
et al., 2005) and HBV ENH1 CAT by HBx57–148 (pHECx2CAT)
(Murakami et al., 1994), although DDB1-binding was not examined in
those studies. Finally, the HBxR96E mutant used in the present study
failed to transactivate HBV ENH1 luciferase expression, providing further
support of the importance of HBx-DDB1 binding to the transactivation of
HBV ENH1 (Li et al., 2010).
While HBx transactivation of HBV ENH1 luciferase in the present
study was modest, it was reproducible and in agreement with previous
reports in which HBx expression caused a 2- to 4-fold increase in ENH1
activation (Cha et al., 2009; Tang et al., 2005).We note that low levels of
transactivation in transient transfection assaysmay reﬂect the differen-
tiated state of the cells. A comparison of HBV enhancer activity intransfected cells versus mouse liver revealed 100-fold higher levels of
activity in vivo (Du et al., 2008). We conclude that the modest effect of
HBx observed in cultured cells may represent a very signiﬁcant effect
in vivo. This idea is supported by our observation that viremia is reduced
by 95–99% inmice hydrodynamically-injected with pHBVΔX compared
to pHBV, while HBx-deﬁcient replication is reduced by 50% in HepG2
cells [Fig. 3, Keasler et al., 2007].
Available data suggest several possible models for HBx-DDB1
function in HBV replication. During replication, the HBV partially
double-stranded DNA (~dsDNA) genome is converted, in the nucleus,
to cccDNA, which serves as the template for the transcription of viral
mRNAs [reviewed in Seeger et al., 2007]. The HBx-DDB1 cccDNA
model (Fig. 7A) predict that DDB1-binding is required for HBx activa-
tion of viral transcription in the nucleus, and that the carboxyl portion
of HBx is required for its interaction with cellular transcription fac-
tors. There is considerable support for this model. Although HBx lo-
calizes to both the nucleus and the cytoplasm, nuclear-localized HBx
is responsible for maximal HBV replication (Keasler et al., 2009) and
for transactivation of HBV ENH1 (Doria et al., 1995). It is now clear
that HBx-DDB1 binding is required for maximal virus replication
(Fig. 1) (Leupin et al., 2005; Li et al., 2010), and that HBx regulates
the level of HBV mRNA (Keasler et al., 2007, 2009; Melegari et al.,
2005; Tang et al., 2005). The model further suggests that in addition
to HBx-DDB1 binding, maximal HBV replication requires a function
from the carboxyl portion of HBx (Fig. 3B) (Murakami et al., 1994;
Tang et al., 2005). Indeed, previous studies have demonstrated that
several transcription factors bind to the carboxyl portion of HBx
(Choi et al., 1999; Lin et al., 1997). In addition, an X-ray crystallogra-
phy study revealed that HBx-DDB1 binding results in the carboxyl re-
gion of HBx protruding outward from DDB1 where it is accessible to
bind transcription factors (Li et al., 2010). This cccDNA model further
Fig. 7. Models for the role of HBx-DDB1 in virus replication. (A) HBx-DDB1 cccDNA model. During HBV replication, the partially double-stranded DNA genome is repaired to form
cccDNA. This model predicts that HBx (which does not bind DNA) is tethered to the cccDNA via DDB1, and that the carboxyl portion of HBx is needed to recruit transcription factors
(TFs) for the transcription of viral mRNAs, as described in the text. (B) HBx-DDB1 Displacement/Recruitment model. DDB1 functions as an adaptor for the CUL4A E3 ubiquitin ligase
complex, where it recruits DDB1-CUL4 Accessory Factors (DCAFs), which bind substrate proteins that are ubiquinated and degraded by the proteosome. This model proposes that
during HBV replication, the HBx interaction with DDB1 may either displace one or more DCAFs to block the degradation of DCAF substrates that beneﬁt HBV replication, and/or
recruit other substrates either for protection from degradation (positive factor) or for degradation (negative factor).
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demonstrated using a cccDNA-speciﬁc chromatin immunoprecipita-
tion (ChIP)-based assay (Belloni et al., 2009). It is generally accepted
that HBx does not bind dsDNA directly (Rossner, 1992). However,
DDB1 is a well-known DNA-binding protein (Abramic et al., 1991;
Hwang and Chu, 1993). We propose that HBx recruitment to cccDNA
could be facilitated by its interaction with DDB1. This model may help
explain the promiscuity of HBx transactivation, if DDB1 scanning for
damaged DNA brings HBx into contact with many different
promoters.
Additional models for HBx-DDB1 function in virus replication, that
are notmutually exclusive of the cccDNAmodel, arise from our demon-
stration that HBx can localize to theDDB1-Cul4A complex (Fig. 5). DDB1
is an adaptor protein for the Cul4A E3 ligase adaptor, which recruits
DCAFs that bring in various substrates for ubiquitination and proteo-
some degradation (Angers et al., 2006; He et al., 2006; Higa et al.,
2006; Shiyanov et al., 1999). Interestingly, the region of DDB1 to
which HBx binds (Li et al., 2010) is shared by at least 79 DCAFs (He
et al., 2006). Several lines of evidence suggest that HBx is a DCAF.
First, it shares a DWD motif with the known DCAFs (Keasler and
Slagle, 2008; Li et al., 2010). Second, HBx binding to DDB1 can displace
the DCAF DDB2 (Bontron et al., 2002) and woodchuck hepatitis WHx
binding to DDB1 can displace DCAF9 (Li et al., 2010). Finally, data pre-
sent in the present study demonstrate that HBx is actually stabilized
by DDB1, and unlikely to be a substrate of the DDB1 E3 ligase activity
(Fig. 6). We conclude that HBx shares many features of DCAFs.
If HBx acts as a DCAF during HBV replication, we envision that it
could act in either of two ways. First, HBx may act by simply displa-
cing existing DDB1-associated DCAFs. In this DCAF Displacement
Model (Fig. 7B), the DDB1-binding domain of HBx would be sufﬁcient
to displace other DCAFs and result in restoration of HBVΔX replica-
tion. However, we show several HBx truncation mutants that retain
the ability to bind DDB1 but are unable to restore HBx-deﬁcient replica-
tion (Figs. 2, 3, 4). A related model, designated the DCAF Recruitment
Model, predicts that HBx behaves as a DCAF by binding DDB1 and
recruiting a substrate(s) for degradation. HBx could recruit either a
“negative factor” substrate whose degradation would beneﬁt virus rep-
lication, or a “positive factor” substrate that needs to be protected from
degradation. The latter possibility is consistent with HBx being stabi-
lized by endogenous DDB1 (Fig. 6) and is supported by the observation
that proteosome inhibitor MG132 restores HBx-deﬁcient virus replica-
tion but has no effect on wildtype HBV replication (Zhang et al., 2004).
Several viruses encode proteins that bind DDB1-Cul4A, presum-
ably as a mechanism to promote virus replication. The ParamyxovirusSV5 regulatory V protein binds DDB1 (Lin et al., 1998), redirecting the
DDB1-Cul4A E3 ligase to ubiquitinate and degrade STAT1, thereby
inactivating the host interferon antiviral response (Precious et al.,
2005). The HIV1 regulatory Vpr protein also binds DDB1 and redirects
Cul4A ligase activity to induce cell cycle arrest (Le Rouzic et al., 2007;
Schrofelbauer et al., 2007). Murine gamma herpesvirus 68 encodes
the M2 latency protein, which interacts with the Cul4A-DDB1COP9
complex deregulating DNA repair by inhibiting repair signal trans-
duction (Liang et al., 2006). Although there is evidence that HBx can
inactivate the host interferon response (Jiang and Tang, 2011;
Kumar et al., 2011; Wang et al., 2010; Wei et al., 2010), it remains
to be determined whether this occurs in a DDB1-dependent manner.
Similarly, HBx is reported to enhance the progression of G0 hepato-
cytes into G1, both in regenerating liver (Hodgson et al., 2008) and
in primary hepatocytes in culture (Bouchard et al., 2001; Gearhart
and Bouchard, 2010), although a role for DDB1 in this process has
not been investigated. A correlation has been noted between HBx-
DDB1 binding and the inhibition of DNA repair. Notably, HBx69 and
HBx90/91, which do not bind DDB1, do not inhibit DNA repair
(Becker et al., 1998). Additional studies are needed to establish the
functions provided by the HBx-DDB1 interaction that contribute to
virus replication.
Conclusions
The present study examined the requirements of the HBx-DDB1
interaction in the context of HBV replication. After establishing that
HBx-binding to DDB1 is critical for maximal HBV replication, we
went on to show that HBx-DDB1 binding alone is not sufﬁcient to re-
store HBx-deﬁcient replication. Our results demonstrate that addi-
tional regions of HBx residing in the carboxyl portion are required
for virus replication. While the plasmid assays used do not represent
all steps in authentic virus infection, they do allow us to examine HBx
functions in the context of HBV replication. Our results are further
supported by previous studies showing the carboxyl portion of HBx
contains transactivation function, and we additionally demonstrate
that the region of HBx that spans the DDB1-binding domain is re-
quired for transcriptional activation of HBV ENH 1. Together, our
study brings together the role of HBx as a transcriptional activator
and as a DDB1-binding protein, and proposes testable models for
role(s) of HBx-DDB1 in HBV replication. Although the precise func-
tion(s) of DDB1 usurped by HBx and its importance to virus replica-
tion remains to be identiﬁed, the observation that HBx binds to
DDB1may help to explain the diversity of functions proposed for HBx.
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Plasmids and cloning
A plasmid carrying a greater-than-unit-length (129%) HBV ge-
nome (payw1.2; subtype ayw) and the same plasmid with a stop
codon at amino acid 7 of HBx that prevents expression of HBx
(McClain et al., 2007) (payw1.2*7) were previously described
(Melegari et al., 1998; Scaglioni et al., 1997), and are referred to
here as pHBV and pHBVΔX, respectively. A plasmid encoding a
heat-stable, secretable form of alkaline phosphatase (pSI-SEAP) was
used as a negative control (Keasler et al., 2007). A plasmid encoding
myc-tagged Cul4A has been described (Li et al., 2010). A reporter
plasmid in which ﬁreﬂy luciferase is under control of the HBV En-
hancer I (pXStNc-Luc), referred to in this study as ENH1-Luc, was
obtained from Dr. Shinako Takada (MD Anderson Cancer Center,
Houston, TX). A plasmid encoding Renilla luciferase, pSI-RLuc, was
used for normalization and was described previously (Kumar et al.,
2011). pSI plasmids encoding HBx point mutants included HBx7,
HBx69, and HBx90/91 were described previously (Becker et al., 1998).
The plasmid HBxR96E (Lin-Marq et al., 2001) was a kind gift of Dr.
Michel Strubin and was re-cloned into the same pSI vector. HBx trun-
cations were created by PCR cloning from pSI-X [subtype adw2;
Keasler et al., 2007, 2009] into the Mlu I and Not I sites of the pSI vec-
tor (Promega). Truncation mutants included HBx1–101, HBx43–154,
HBx101–154, and HBx55–101, with numbers indicating the amino acids
present in the truncated protein. In addition, PCR ampliﬁcation was
used to add two N-terminal HA epitope-tags (YPYDVPDYA)
(Helliwell et al., 2001) and a C-terminal hexahistidine tag to the
HBx truncation constructs. A full-length HBx with a N-terminal HA-
tag was generated similarly. Plasmid constructs were conﬁrmed by
DNA sequencing (Lone Star Labs, Houston, TX and Epoch LifeSciences,
Missouri City, TX).
Cell culture and transfections
HepG2 cells obtained from the ATCC were maintained in Eagle's
media as described previously (Keasler et al., 2007) and used at an
early passage. Cells were plated at 1×105 cells per well in 6-well
plates for replication assays, at 5×104 cells per well in 24-well plates
for luciferase assays, or at 5×105 cells per 60-mm dish for western
blots. Cells were allowed to adhere overnight before being transfected
using TransIT-LT1 reagent (Mirus Bio Corporation) according to the
manufacturer's directions. For replication assays, 1×106 untrans-
fected HepG2 cells were added to each well 2 h post-transfection in
order to create a conﬂuent monolayer needed for HBx-dependent
replication (Keasler et al., 2007).
Puriﬁcation of capsid-associated viral DNA
Capsid-associated DNA was extracted as described previously
(Keasler et al., 2007, 2009), with modiﬁcations as reported (Kumar
et al., 2011). Three days after transfection, capsid-associated viral
DNA was isolated from HepG2 cell lysates using the QIAampMinElute
Virus Spin kit (Qiagen).
Real-time PCR detection of HBV DNA
Capsid-associated DNA was quantitated using TaqMan real-time
PCR, as previously described (Keasler et al., 2007, 2009; Kumar
et al., 2011). Triplicate samples were analyzed in duplicate PCR
wells using 5 μL of isolated DNA. Copy number was determined
from standard curve (107–100) as described (Keasler et al., 2007,
2009). All samples were compared as a percentage of the copy num-
ber measured in cells transfected with wild type pHBV. Results were
conﬁrmed in three independent experiments.Immunoprecipitation (IP) and western blot
To detect wildtype and mutant HBx, transfected HEK 293 T cells
from four 60-mm plates were pooled and lysed in 400 μL phosphate
buffered saline (PBS) supplemented with 1% sodium dodecelsulfate
(SDS) and 0.1 mg/mL DNase I. Samples were resolved by SDS poly-
acrylamide gel electrophoresis (PAGE) and transferred onto a nitro-
cellulose membrane (Schleicher & Schuell Bioscience). Membranes
were ﬁxed with 0.5% gluteraldehyde (Sigma-Aldrich) in PBS for
15 min, washed in PBS for 30 min, and then blocked with 5% non-
fat dry milk in PBS (BLOTTO) for 15 min. Full-length HBx point mu-
tant proteins were detected by a rabbit sera raised against HBx from
HBV subtype adw2, diluted 1:1000 in 0.5% BLOTTO and 0.5% Tween
20 (BLOTTO-T). The HA-tagged HBx truncation proteins were
detected using an anti-HA monoclonal antibody (Covance) diluted
1:1000 in 0.5% BLOTTO-T. Membraneswere incubated in primary anti-
body overnight at 4 °C, and then with alkaline phosphatase-conjugated
secondary antibodies, diluted 1:3000 in 0.5% BLOTTO-T, for 2 h at room
temperature. Blots were developed with a colorimetric substrate
[50 mM Tris base, 3 mMMgCl2, 0.1 mg/mL nitro-blue tetrazolium chlo-
ride (NBT) and 0.5 mg/mL 5-bromo-4-chloro-3′-indolyphosphate p-
toluidine salt (BCIP)].
The myc-Cul4A complex was detected by ﬁrst using IP with mouse
anti-myc (Santa Cruz; 1:1000), and then separating proteins by 10%
SDS-PAGE, and analyzing by western blot using the primary anti-
bodies mouse anti-myc (Santa Cruz; 1:1000), mouse anti-DDB1
(Zymed; 1:1000), and rabbit anti-HBx (1:1000). All immunoblots of
IP samples were detected using the SuperSignal® West Femto Sub-
strate kit (Pierce).
Liver extracts were prepared by homogenizing liver in extraction
buffer (50 mM Tris–HCl, 100 mM NaCl, 1 mM EDTA, 1% NP-40, and
1% aprotinin). For the detection of DDB1, a total of 50 μg protein
from each liver was separated by 10% SDS-PAGE and transferred to
a nitrocellulose membrane. The membrane was incubated with either
rabbit anti-DDB1 (Zymed; 1:1000) or anti-tubulin (Santa Cruz;
1:1000). Membranes were then incubated with horseradish peroxi-
dase conjugated secondary antibody (Pierce; 1:1000). HBx was
detected by IP from 3 mg liver lysate using rabbit anti-HBx serum
(1:1000). Sequential IP was done by incubating the remaining IP su-
pernatant with additional rabbit anti-HBx serum (1:1000). Samples
were separated by 15% SDS-PAGE, as previously described (Madden
et al., 2000), and analyzed by western blot using the primary rabbit
anti-HBx serum (1:1000) and secondary anti-rabbit antibody (Pierce;
1:1000). Bound antibody was detected using the SuperSignal West
Femto kit (Pierce). To compare levels of DDB1, western blots for
DDB1 and for tubulin were quantitated by densitometry (Molecular
Dynamics), analyzed by ImageQuant5.2 software, and DDB1 was nor-
malized to tubulin within the same sample.
Luciferase assay
HepG2 cells were cotransfected with ENH1-Luc, pSI-Rluc, and
combinations of pSI-X, pSI-X mutants, or the pSI vector control, as in-
dicated. Cells were harvested 24 h post-transfection and lysed with
Passive Lysis Buffer (Promega). Fireﬂy and Renilla luciferase activities
were determined using the Dual-Luciferase Reporter Assay (Pro-
mega) according to manufacturer's directions. Readings were nor-
malized to Renilla luciferase within a sample group. Activation of
the luciferase construct in the absence of HBx was set to 1.0 and
fold activation in the presence of HBx or HBx mutants was calculated.
Transgenic mice and hydrodynamic injections
Approval for all experiments involving mice was obtained from
the Institutional Animal Care and Use Committee at Baylor College
of Medicine. Mice harboring two ﬂoxed alleles of DDB1 (DDB1F/F)
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under control of the α-1-antitrypsin regulatory region (Lee et al.,
1990). These double-transgenic mice were then crossed with mice
transgenic for the Cre recombinase under the liver-speciﬁc control
of the albumin promoter (Alb-Cre+/−) on a DDB1F/F background.
Resulting progeny were genotyped by PCR analysis of high molecular
weight DNA from tail clippings (Transnetyx).
Hydrodynamic injections were performed on outbred Crl:CD-1
(ICR) mice at 10–13 weeks of age as previously described (Keasler
et al., 2007, 2009). Brieﬂy, mice were injected with plasmid DNA di-
luted in phosphate-buffered saline to a volume equivalent to 8% of
the total body weight per animal. Each injected mouse received a
total of 18 μg plasmid DNA: 9 μg of HBV plasmid DNA (either pHBV
or pHBVΔX), 5 μg of plasmid DNA encoding heat-stable, secretable al-
kaline phosphatase (pSI-SEAP), and 4 μg of pSI-X, pSI-X55–101, or con-
trol plasmid. Negative control animals received 18 μg plasmid DNA:
5 μg pSI-SEAP and 13 μg of promoterless pSEAP2-Basic plasmid DNA.
Mice were sacriﬁced on day 4 post-injection at the peak of viremia
(Keasler et al., 2007; Yang et al., 2002), and blood was collected and
livers harvested. HBV copy number in the serum was determined by
real time PCR quantitation of capsid-associated viral DNA, as previ-
ously described (Keasler et al., 2007, 2009). 10 μL serum was heated
to 65 °C for 30 min to inactivate endogenouse phosphatase, and
then diluted 1:25 in saline for measurement of secretable alkaline
phosphatase as a serum marker of transfection efﬁciency, as de-
scribed (Keasler et al., 2007).
Immunostaining
Formalin ﬁxed, parafﬁn-embedded mouse liver samples were exam-
ined for DDB1 expression. Deparafﬁnized liver sectionswere ﬁrst treated
with Target Retrieval Solution (Dako) at 121 °C for 5 min. Following
blocking steps, sections were incubated with primary anti-DDB1 (Bethyl
Labs, 1:100), secondary antibody (goat anti-rabbit; Vector, 1:200), and
Avidin–biotin complex (Vectastain Elite ABC; Vector).
Quantitation and statistical analysis
All resultswere conﬁrmed in at least three independent experiments.
Statistical signiﬁcancewas determined using the Student's T-test (Micro-
soft Excel software package). Error bars shown in ﬁgures indicate stan-
dard error of the mean, unless otherwise indicated. Statistical
signiﬁcance assigned for pb0.05.
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